GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Rainmed Medical Ltd (HKSE:02297) » Definitions » Beneish M-Score

Rainmed Medical (HKSE:02297) Beneish M-Score : -1.63 (As of Jun. 19, 2024)


View and export this data going back to 2022. Start your Free Trial

What is Rainmed Medical Beneish M-Score?

The zones of discrimination for M-Score is as such:

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator.
An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Warning Sign:

Beneish M-Score -1.63 higher than -1.78, which implies that the company might have manipulated its financial results.

The historical rank and industry rank for Rainmed Medical's Beneish M-Score or its related term are showing as below:

HKSE:02297' s Beneish M-Score Range Over the Past 10 Years
Min: -1.63   Med: 5.31   Max: 12.25
Current: -1.63

During the past 4 years, the highest Beneish M-Score of Rainmed Medical was 12.25. The lowest was -1.63. And the median was 5.31.


Rainmed Medical Beneish M-Score Historical Data

The historical data trend for Rainmed Medical's Beneish M-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Rainmed Medical Beneish M-Score Chart

Rainmed Medical Annual Data
Trend Dec20 Dec21 Dec22 Dec23
Beneish M-Score
- - 12.25 -1.63

Rainmed Medical Semi-Annual Data
Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Beneish M-Score Get a 7-Day Free Trial - - 12.25 - -1.63

Competitive Comparison of Rainmed Medical's Beneish M-Score

For the Medical Devices subindustry, Rainmed Medical's Beneish M-Score, along with its competitors' market caps and Beneish M-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Rainmed Medical's Beneish M-Score Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Rainmed Medical's Beneish M-Score distribution charts can be found below:

* The bar in red indicates where Rainmed Medical's Beneish M-Score falls into.



Rainmed Medical Beneish M-Score Calculation

The M-score was created by Professor Messod Beneish. Instead of measuring the bankruptcy risk (Altman Z-Score) or business trend (Piotroski F-Score), M-score can be used to detect the risk of earnings manipulation. This is the original research paper on M-score.

The M-Score Variables:

The M-score of Rainmed Medical for today is based on a combination of the following eight different indices:

M=-4.84+0.92 * DSRI+0.528 * GMI+0.404 * AQI+0.892 * SGI+0.115 * DEPI
=-4.84+0.92 * 1.1742+0.528 * 1.2595+0.404 * 2.1615+0.892 * 0.8578+0.115 * 1.8919
-0.172 * SGAI+4.679 * TATA-0.327 * LVGI
-0.172 * 0.9589+4.679 * 0.014756-0.327 * 0.8906
=-1.63

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Dec23) TTM:Last Year (Dec22) TTM:
Total Receivables was HK$11.32 Mil.
Revenue was HK$80.09 Mil.
Gross Profit was HK$53.11 Mil.
Total Current Assets was HK$403.84 Mil.
Total Assets was HK$627.07 Mil.
Property, Plant and Equipment(Net PPE) was HK$128.68 Mil.
Depreciation, Depletion and Amortization(DDA) was HK$24.32 Mil.
Selling, General, & Admin. Expense(SGA) was HK$99.29 Mil.
Total Current Liabilities was HK$44.83 Mil.
Long-Term Debt & Capital Lease Obligation was HK$13.18 Mil.
Net Income was HK$-126.69 Mil.
Gross Profit was HK$0.00 Mil.
Cash Flow from Operations was HK$-135.95 Mil.
Total Receivables was HK$11.24 Mil.
Revenue was HK$93.36 Mil.
Gross Profit was HK$77.97 Mil.
Total Current Assets was HK$673.86 Mil.
Total Assets was HK$770.90 Mil.
Property, Plant and Equipment(Net PPE) was HK$43.26 Mil.
Depreciation, Depletion and Amortization(DDA) was HK$18.61 Mil.
Selling, General, & Admin. Expense(SGA) was HK$120.71 Mil.
Total Current Liabilities was HK$76.07 Mil.
Long-Term Debt & Capital Lease Obligation was HK$3.99 Mil.




1. DSRI = Days Sales in Receivables Index

Measured as the ratio of Revenue in Total Receivables in year t to year t-1.

A large increase in DSR could be indicative of revenue inflation.

DSRI=(Receivables_t / Revenue_t) / (Receivables_t-1 / Revenue_t-1)
=(11.321 / 80.085) / (11.24 / 93.362)
=0.141362 / 0.120392
=1.1742

2. GMI = Gross Margin Index

Measured as the ratio of gross margin in year t-1 to gross margin in year t.

Gross margin has deteriorated when this index is above 1. A firm with poorer prospects is more likely to manipulate earnings.

GMI=GrossMargin_t-1 / GrossMargin_t
=(GrossProfit_t-1 / Revenue_t-1) / (GrossProfit_t / Revenue_t)
=(77.973 / 93.362) / (53.106 / 80.085)
=0.835168 / 0.66312
=1.2595

3. AQI = Asset Quality Index

AQI is the ratio of asset quality in year t to year t-1.

Asset quality is measured as the ratio of non-current assets other than Property, Plant and Equipment to Total Assets.

AQI=(1 - (CurrentAssets_t + PPE_t) / TotalAssets_t) / (1 - (CurrentAssets_t-1 + PPE_t-1) / TotalAssets_t-1)
=(1 - (403.84 + 128.684) / 627.072) / (1 - (673.863 + 43.264) / 770.902)
=0.150777 / 0.069756
=2.1615

4. SGI = Sales Growth Index

Ratio of Revenue in year t to sales in year t-1.

Sales growth is not itself a measure of manipulation. However, growth companies are likely to find themselves under pressure to manipulate in order to keep up appearances.

SGI=Sales_t / Sales_t-1
=Revenue_t / Revenue_t-1
=80.085 / 93.362
=0.8578

5. DEPI = Depreciation Index

Measured as the ratio of the rate of Depreciation, Depletion and Amortization in year t-1 to the corresponding rate in year t.

DEPI greater than 1 indicates that assets are being depreciated at a slower rate. This suggests that the firm might be revising useful asset life assumptions upwards, or adopting a new method that is income friendly.

DEPI=(Depreciation_t-1 / (Depreciaton_t-1 + PPE_t-1)) / (Depreciation_t / (Depreciaton_t + PPE_t))
=(18.607 / (18.607 + 43.264)) / (24.322 / (24.322 + 128.684))
=0.300739 / 0.158961
=1.8919

Note: If the Depreciation, Depletion and Amortization data is not available, we assume that the depreciation rate is constant and set the Depreciation Index to 1.

6. SGAI = Sales, General and Administrative expenses Index

The ratio of Selling, General, & Admin. Expense(SGA) to Sales in year t relative to year t-1.

SGA expenses index > 1 means that the company is becoming less efficient in generate sales.

SGAI=(SGA_t / Sales_t) / (SGA_t-1 /Sales_t-1)
=(99.29 / 80.085) / (120.709 / 93.362)
=1.239808 / 1.292914
=0.9589

7. LVGI = Leverage Index

The ratio of total debt to Total Assets in year t relative to yeat t-1.

An LVGI > 1 indicates an increase in leverage

LVGI=((LTD_t + CurrentLiabilities_t) / TotalAssets_t) / ((LTD_t-1 + CurrentLiabilities_t-1) / TotalAssets_t-1)
=((13.175 + 44.825) / 627.072) / ((3.992 + 76.069) / 770.902)
=0.092493 / 0.103854
=0.8906

8. TATA = Total Accruals to Total Assets

Total accruals calculated as the change in working capital accounts other than cash less depreciation.

TATA=(IncomefromContinuingOperations_t - CashFlowsfromOperations_t) / TotalAssets_t
=(NetIncome_t - NonOperatingIncome_t - CashFlowsfromOperations_t) / TotalAssets_t
=(-126.692 - 0 - -135.945) / 627.072
=0.014756

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator. An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Rainmed Medical has a M-score of -1.63 signals that the company is likely to be a manipulator.


Rainmed Medical Beneish M-Score Related Terms

Thank you for viewing the detailed overview of Rainmed Medical's Beneish M-Score provided by GuruFocus.com. Please click on the following links to see related term pages.


Rainmed Medical (HKSE:02297) Business Description

Traded in Other Exchanges
N/A
Address
No. 99, Jinji Lake Avenue, Building 31, Northeast District, Suzhou Industrial Park, Jiangsu Province, Suzhou, CHN, 215000
Rainmed Medical Ltd is focused on the design, development, and commercialization of coronary angiography-derived fractional flow reserve systems and coronary angiography-derived index of microcirculatory resistance systems. The company's core products, the caFFR system and the caIMR system are innovative medical devices used to evaluate the severity of myocardial ischemia arising from coronary artery stenosis and microvascular dysfunction, which are the underlying causes of coronary artery diseases (CAD).
Executives
Huo Yunfei 2101 Beneficial owner
Zhou Bin
Zhong Guo Ping An Bao Xian Ji Tuan Gu Fen You Xian Gong Si
Xi Zang Jing Jia Qi Ye Guan Li You Xian Ze Ren Gong Si
Shang Hai Jing Lin Gu Quan Tou Zi Guan Li You Xian Gong Si
Shang Hai Jing Wu Tou Zi Zhong Xin You Xian He Huo
Shang Hai Jing Mai Run Qi Ye Guan Li Zhong Xin You Xian He Huo
Gong Qing Cheng Jing Cheng Yu Tou Zi Guan Li He Huo Qi Ye You Xian He Huo
Gong Qing Cheng Jing Lin Jing Jia Tou Zi Guan Li He Huo Qi Ye You Xian He Huo
Jing Lin Zi Ben Guan Li You Xian Gong Si
Shen Zhen Jing Lin Jing Ying Gu Quan Tou Zi Ji Jin He Huo Qi Ye You Xian He Huo
Shen Zhen Jing Hui Gu Quan Tou Zi Guan Li He Huo Qi Ye You Xian He Huo
Shang Hai Tong Xiang Hao Qian Qi Ye Guan Li He Huo Qi Ye You Xian He Huo
Xi Zang Jing Ning Qi Ye Guan Li You Xian Ze Ren Gong Si
Liu Li Rui

Rainmed Medical (HKSE:02297) Headlines

No Headlines